Themis Medicare Limited

Themis Medicare Limited (THEMISMED) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

themismedicare.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹124.15
Market cap
1,144 Cr
Stock P/E
21.3
P/B
2.88
Dividend yield
0.4%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales105 Cr83 Cr98 Cr123 Cr117 Cr94 Cr72 Cr98 Cr78 Cr90 Cr77 Cr87 Cr
Operating expenses (approx.)92 Cr74 Cr89 Cr94 Cr100 Cr85 Cr77 Cr108 Cr81 Cr80 Cr73 Cr139 Cr
EBITDA12 Cr8 Cr9 Cr29 Cr17 Cr9 Cr-6 Cr-10 Cr-3 Cr10 Cr4 Cr-52 Cr
OPM %11.8%9.8%9.5%23.7%14.6%9.1%-8.1%-10.3%-4.0%10.9%4.9%-60.3%
Other income2 Cr0.56 Cr1 Cr0.96 Cr1 Cr1 Cr2 Cr1 Cr3 Cr1 Cr4 Cr0.99 Cr
Interest2 Cr3 Cr2 Cr2 Cr2 Cr3 Cr2 Cr2 Cr3 Cr3 Cr3 Cr3 Cr
Depreciation3 Cr3 Cr3 Cr2 Cr2 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr
Profit before tax14 Cr8 Cr9 Cr31 Cr18 Cr2 Cr-11 Cr-14 Cr-3 Cr10 Cr9 Cr39 Cr
Tax %18.9%10.3%24.1%21.3%19.7%68.7%13.1%-1.1%-4.8%2.8%1.9%36.2%
Net profit11 Cr7 Cr7 Cr25 Cr14 Cr0.52 Cr-10 Cr-14 Cr-4 Cr10 Cr9 Cr25 Cr
EPS (₹)₹12.30₹0.80₹0.72₹2.68₹1.55₹0.06₹-1.05₹-1.54₹-0.39₹1.10₹0.96₹2.67

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales184 Cr202 Cr231 Cr395 Cr354 Cr382 Cr406 Cr342 CrSign in for TTM
Operating expenses (approx.)181 Cr166 Cr181 Cr299 Cr287 Cr330 Cr356 Cr342 CrSign in for TTM
EBITDA2 Cr36 Cr49 Cr96 Cr67 Cr52 Cr49 Cr0.39 CrSign in for TTM
OPM %1.2%17.7%21.5%24.2%19.0%13.5%12.1%0.1%Sign in for TTM
Other income3 Cr3 Cr4 Cr7 Cr12 Cr5 Cr5 Cr9 CrSign in for TTM
Interest12 Cr13 Cr13 Cr9 Cr10 Cr9 Cr10 Cr11 CrSign in for TTM
Depreciation8 Cr8 Cr9 Cr9 Cr10 Cr12 Cr10 Cr10 CrSign in for TTM
Profit before tax-13 Cr27 Cr41 Cr95 Cr73 Cr53 Cr40 Cr2 CrSign in for TTM
Tax %14.6%7.8%13.6%23.5%21.5%18.6%24.8%40.7%Sign in for TTM
Net profit-11 Cr25 Cr36 Cr73 Cr57 Cr44 Cr30 Cr1 CrSign in for TTM
EPS (₹)₹-11.72₹26.97₹38.86₹79.22₹61.83₹4.73₹3.24₹0.12Sign in for TTM
Dividend payout %———5.4%8.1%10.6%15.4%402.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr
Reserves149 Cr174 Cr209 Cr278 Cr330 Cr368 Cr393 Cr389 Cr
Borrowings76 Cr88 Cr79 Cr79 Cr92 Cr96 Cr83 Cr100 Cr
Other liabilities80 Cr78 Cr74 Cr62 Cr83 Cr93 Cr102 Cr99 Cr
Total liabilities314 Cr350 Cr371 Cr428 Cr514 Cr566 Cr588 Cr598 Cr
Fixed assets (net)122 Cr115 Cr130 Cr142 Cr161 Cr168 Cr172 Cr166 Cr
CWIP2 Cr8 Cr2 Cr3 Cr3 Cr3 Cr3 Cr2 Cr
Investments27 Cr35 Cr45 Cr56 Cr70 Cr89 Cr95 Cr109 Cr
Inventories54 Cr55 Cr58 Cr61 Cr69 Cr71 Cr84 Cr81 Cr
Trade receivables73 Cr102 Cr78 Cr101 Cr145 Cr178 Cr177 Cr178 Cr
Cash & bank2 Cr3 Cr19 Cr20 Cr13 Cr10 Cr7 Cr5 Cr
Other assets35 Cr32 Cr39 Cr45 Cr54 Cr49 Cr51 Cr56 Cr
Total assets314 Cr350 Cr371 Cr428 Cr514 Cr566 Cr588 Cr598 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———34 Cr16 Cr14 Cr35 Cr-3 Cr
Cash from investing———-15 Cr-24 Cr-16 Cr-12 Cr-3 Cr
Cash from financing———-18 Cr0.14 Cr-1 Cr-26 Cr4 Cr
Net cash flow———2 Cr-8 Cr-3 Cr-3 Cr-2 Cr
Free cash flow (OCF − Capex)———14 Cr-13 Cr-4 Cr19 Cr-8 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022BSE balance sheet (this exchange's own filing had none for this period)Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %-0.6%26.9%18.2%41.1%19.0%13.3%10.2%2.5%
ROE %-8.8%16.7%18.1%28.8%16.8%11.5%7.4%0.3%
Debtor days14418612293149170159189
Inventory days397388313195261304402515
Days payable259211165102152204245323
Cash conversion cycle282363271185259270316382
Debt / equity0.480.480.360.270.270.250.210.25
Current ratio1.021.171.451.961.901.901.951.84
Net debt / EBITDA0.000.000.000.001.181.671.56243.01

Compare with peers

Loading peers…